Why the study?
Does female gender affect the clinical, echocardiographic, and survival response to cardiac resynchronization therapy in patients with end-stage heart failure?
Does female gender affect the clinical, echocardiographic, and survival response to cardiac resynchronization therapy in patients with end-stage heart failure?
Cardiac resynchronization therapy provides similar clinical, echocardiographic, and long-term survival benefits in both men and women with end-stage heart failure.
Answers are grounded in this paper and cite their sources.
CRT response similar by sex in this cohort; leaves open whether sex-specific selection criteria are warranted in prospective trials.
BACKGROUND: Cardiac resynchronization therapy (CRT) has a beneficial effect on clinical symptoms, exercise capacity, and systolic left ventricular (LV) performance in patients with heart failure. The aim of the current study was to evaluate whether a gender difference exists in response to CRT. METHODS: Consecutive patients with end-stage heart failure (New York Heart Association, NYHA, class III-IV), LV ejection fraction (LVEF) < or =35%, QRS duration >120 ms, and left bundle branch block configuration underwent CRT. At baseline and 6 months post-CRT, clinical and echocardiographic parameters were evaluated; follow-up was obtained up to 5 years. The effects of CRT were compared between women and men. RESULTS: The study population comprised 137 men and 36 women (mean age 66 +/- 11 years). No differences in baseline characteristics were observed except that nonischemic cardiomyopathy was more frequent in women than men (67% vs 38%, P < 0.05). In all patients, clinical and echocardiographic parameters improved significantly at 6-month follow-up. The magnitude of improvement in different parameters was similar between women and men, e.g., the improvement in NYHA Class was 0.9 +/- 0.6 in women and 1.0 +/- 0.7 in men (NS) and the increase in LVEF was 8 +/- 8% in women as compared to 7 +/- 9% in men (NS). The percentage of individual responders was not different between women and men (76% vs 80%, NS) and 2-year survival was comparable for women and men (84% vs 80%, NS). CONCLUSION: No gender differences were observed in response to CRT and long-term survival after CRT.
No takes yet. Share an insight, caveat, or question.
Bleeker et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: